Hi kin ,
I was referring to the ann late july , re NAL receiving
'unsolicited approaches , in relation to the technology , from a number of sources.'
From what i have experienced the aus market undervalues aus tech, here specifically bio , and the true value is only often seen when a large pharma gobbles one of ours up.
- Forums
- ASX - By Stock
- NAL
- rights issue
rights issue, page-11
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)